Olga Ovcinnikova
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Cost-Effectiveness of 9-Valent HPV Vaccination for Patients Treated for High-Grade Cervical Intraepithelial Neoplasia in the UK.
Journal: JAMA network open
Published: October 04, 2024
Burden and indirect cost of vaccine-preventable cancer mortality in Europe.
Journal: Journal of medical economics
Published: July 16, 2024
Productivity costs due to human papillomavirus-related cancer mortality in the United Kingdom.
Journal: Journal of medical economics
Published: June 18, 2024
"A systematic literature review of the epidemiology, clinical, economic and humanistic burden in recurrent respiratory papillomatosis".
Journal: Respiratory research
Published: June 05, 2024
The clinical and economic burden of peripheral T-cell lymphoma: a systematic literature review.
Journal: Future oncology (London, England)
Published: December 01, 2021
Assessing the Health and Economic Outcomes of a 9-Valent HPV Vaccination Program in the United Kingdom.
Journal: Journal of health economics and outcomes research
Published: November 30, 2021
Real-World Evidence in Healthcare Decision Making: Global Trends and Case Studies From Latin America.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: September 21, 2018
Relative cost-effectiveness of an extensively hydrolyzed casein formula containing the probiotic Lactobacillus rhamnosus GG in managing infants with cow's milk allergy in Italy.
Journal: ClinicoEconomics and outcomes research : CEOR
Published: June 20, 2015
Cost-effectiveness of using an extensively hydrolyzed casein formula plus the probiotic Lactobacillus rhamnosus GG compared to an extensively hydrolyzed formula alone or an amino acid formula as first-line dietary management for cow's milk allergy in the US.
Journal: ClinicoEconomics and outcomes research : CEOR
Published: March 14, 2015
Cost Effectiveness of Cetuximab in 1st-Line Treatment of RAS Wild-Type Metastatic Colorectal Cancer in Scotland: A Summary of the Submission to the Scottish Medicines Consortium.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: November 01, 2014
An Analysis of the Health Technology Assessment Recommendation and Guidance on Use of Eq-5d-5l in Cost-Effectiveness Modeling.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: November 01, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026